Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Extracellular regulated kinase (ERK)-dependent regulation of sialomucin complex/rat Muc4 in mammary epithelial cells

Abstract

Sialomucin complex (SMC, rat Muc4) is a membrane mucin implicated in the protection of epithelia and the metastasis of some tumors. It is a heterodimeric complex, containing a mucin subunit with anti-adhesive activity and a transmembrane subunit with epidermal growth factor-like domains, one of which acts as an intramembrane ligand for ErbB2. Serum, insulin and insulin-like growth factor, but not epidermal growth factor, induce the expression of sialomucin complex in mammary epithelial cells. Induction correlates with sustained, but not transient, activation of extracellular-regulated protein kinase (ERK). MEK inhibitor U0126 blocked the induction, while activated MEK-1 transfected into a rat mammary adenocarcinoma cell line induced a sustained activation of ERK and up-regulated SMC/Muc4 expression. Northern and Western blotting indicated that up-regulation occurred concomitantly at the transcript and protein levels, both of which could be blocked by U0126. These results suggest that expression of SMC/Muc4 in mammary epithelial cells is regulated by selected growth factors through an ERK-dependent pathway at the transcript level.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S-I, Itoh N, Shibuya M and Fukami Y. . 1987 J. Cell Sci. 99: 407–417.

  • Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinhok RA, Panayotatos N, Cobb MH and Yancopoulos GD. . 1991 Cell 65: 663–674.

  • Cahill AL and Perlman RL. . 1991 J. Neurochem. 57: 1832–1839.

  • Carraway KL III, Rossi EA, Komatsu M, Price-Schiavi SA, Huang D, Guy PM, Carvajal ME, Fregien N, Carraway CAC and Carraway KL. . 1999 J. Biol. Chem. 274: 5263–5266.

  • Chen Q, Kinch MS, Lin TH, Burridge K and Juliano RL. . 1994 J. Biol. Chem. 269: 26602–26605.

  • Coleman S and Daniel CW. . 1990 Dev. Biol. 137: 425–433.

  • Frodin M and Gammeltoft S. . 1999 Mol. Cell Endocrinol. 151: 65–77.

  • Hadsell DL, Greenberg NM, Fligger JM, Baumrucker CR and Rosen JM. . 1996 Endocrinology 136: 321–330.

  • Hull SR, Sheng Z, Vanderpuye OA, David C and Carraway KL. . 1990 Biochem. J. 265: 121–129.

  • Juang S-H, Carvajal ME, Whitney M, Liu Y and Carraway CAC. . 1996 Oncogene 12: 1033–1042.

  • Kleinberg DL. . 1998 Breast Cancer Res. Treat. 47: 201–208.

  • Komatsu M, Carraway CAC, Fregien NL and Carraway KL. . 1997 J. Biol. Chem. 272: 33245–33254.

  • Komatsu M, Tatum L, Altman NH, Carraway CAC and Carraway KL. . 2000 Int. J. Cancer 87: 480-486.

  • Komatsu M, Yee L and Carraway KL. . 1999 Cancer Res. 59: 2229–2236.

  • Levitski A, Gazit A, Osheror N, Posner I and Gilon C. . 1991 Meth. Enzymol. 201: 347–361.

  • Marais R, Wynne J and Treisman R. . 1993 Cell 73: 381–393.

  • Marte BM, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y and Hynes NE. . 1995 Mol. Endocrinology 9: 14–23.

  • McCawley LJ, Li S, Wattenberg EV and Hudson LG. . 1999 J. Biol. Chem. 274: 4347–4353.

  • McNeer RR, Carraway CAC, Fregien N and Carraway KL. . 1998a J. Cell. Physiol. 176: 110–119.

  • McNeer RR, Huang D, Fregien NL and Carraway KL. . 1998b Biochem. J. 330: 737–744.

  • McNeer RR, Price-Schiavi SA, Komatsu M, Fregien N, Carraway CAC and Carraway KL. . 1997 Front. Bioscience. 2: 449–459.

  • Merlo GR, Graus-Porta D, Cella N, Marte BM, Taverna D and Hynes NE. . 1996 Eur. J. Cell. Biol. 70: 97–105.

  • Moniaux N, Nollet S, Porchet N, Degand P, Laine A and Aubert JP. . 1999 Biochem. J. 338: 325–333.

  • Neuenschwander S, Schwartz A, Wood TL, Roberts CTJ, Hennighausen L and LeRoith D. . 1996 J. Clin. Invest. 97: 2225–2232.

  • Nicholas KR, Sankaran L and Topper YJ. . 1983 Biochim. Biophys. Acta 763: 309–314.

  • Porchet N, Nguyen VC, Dufosse J, Audie JP, Guyonnet Duperat V, Gross MS, Denis C, Degand P, Bernheim A and Aubert JP. . 1991 Biochem. Biophys. Res. Commun. 175: 414–422.

  • Price-Schiavi SA, Carraway CAC, Fregien N and Carraway KL. . 1998 J. Biol. Chem. 273: 35228–35237.

  • Price-Schiavi SA, Perez A, Barco R and Carraway KL. . 2000a Biochem. J. 349: 641-649.

  • Price-Schiavi SA, Zhu X, Aquinin R and Carraway KL. . 2000b J. Biol. Chem. 275: 17800-17807.

  • Prosser CG, Sankaran L, Hennighausen L and Topper YJ. . 1987 Endocrinology 120: 1411–1416.

  • Rossi EA, McNeer R, Price-Schiavi SA, Komatsu M, Van den Brande JMH, Thompson JF, Carraway CAC, Fregien NL and Carraway KL. . 1996 J. Biol. Chem. 271: 33476–33485.

  • Ruan W and Kleinberg DL. . 1999 Endocrinology 140: 5075–5081.

  • Ruan W, Catanese W, Wieczorek R, Feldman M and Kleinberg DL. . 1995 Endocrinology 136: 1296–1302.

  • Ruan W, Newman CB and Kleinberg DL. . 1992 Proc. Natl. Acad. Sci. USA 89: 10872–10876.

  • Sheng Z, Hull SR and Carraway KL. . 1990 J. Biol. Chem. 265: 8505–8510.

  • Sheng Z, Wu K, Carraway KL and Fregien N. . 1992 J. Biol. Chem. 267: 16341–16346.

  • Sherblom AP and Carraway KL. . 1980 J. Biol. Chem. 255: 12051–12059.

  • Sherblom AP, Buck RL and Carraway KL. . 1980 J. Biol. Chem. 255: 783–790.

  • Spitzer E, Zschiesche W, Binas B, Grosse R and Erdmann B. . 1995 J. Cell. Biochem. 57: 495–508.

  • Swantek JL and Baserga R. . 1999 Endcocrinology 140: 3163–3169.

  • Taketani Y and Oka T. . 1983a FEBS Lett. 152: 256–260.

  • Taketani Y and Oka T. . 1983b Proc. Natl. Acad. Sci. USA 80: 2647–2650.

  • Tamaoki T, Nomoto H, Takahasi I, Kato Y, Morimoto M and Tomita F. . 1986 Biochem. Biophys. Res. Commun. 135: 397–402.

  • Thomas G. . 1992 Cell 68: 3–6.

  • Voytovich AE, Owens IS and Topper YJ. . 1969 Proc. Natl. Acad. Sci. USA 63: 213–217.

  • Wartmann M, Cella N, Hofer P, Groner B, Liu X, Hennighausen L and Hynes NE. . 1996 J. Biol. Chem. 271: 31863–31868.

  • Waskiewicz AJ and Cooper JA. . 1995 Curr. Opin. Cell Biol. 7: 798–805.

  • Wu K, Fregien N and Carraway KL. . 1994 J. Biol. Chem. 269: 11950–11955.

  • Zhu X and Assoian RK. . 1995 Mol. Biol. Cell. 6: 273–282.

  • Zhu X, Ohtsubo M, Bohmer RM, Roberts JM and Assoian RK. . 1996 J. Cell Biol. 133: 391–403.

Download references

Acknowledgements

We thank Dr Michael Weber, University of Virginia, for generously providing the plasmid pCMV-HA/Mek-1 (S218/222D) use for transfection studies. This research was supported in part by Grant CA52498 from the National Institutes of Health, a predoctoral fellowship DAMD17-97-1-7151 from the Department of the Army Breast Cancer Research Program and by the Sylvester Comprehensive Cancer Center of the University of Miami.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, X., Price-Schiavi, S. & Carraway, K. Extracellular regulated kinase (ERK)-dependent regulation of sialomucin complex/rat Muc4 in mammary epithelial cells. Oncogene 19, 4354–4361 (2000). https://doi.org/10.1038/sj.onc.1203781

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203781

Keywords

This article is cited by

Search

Quick links